hotspot -WSS

hotspot

author：hotspot 2025-10-01 15:29:54 - browse：62712

A yellow number 3 with an eye is surrounded by smaller, black number 3s on a pink background — 3 to watch coverage from STAT — Christine Kao/STAT

Health tech hopefuls might once have been used to a wealth of job options, especially in the pandemic’s early stages when investors pumped record-breaking dollar amounts into an unprecedented number of ventures.

That glut of opportunities meant workers could bargain harder for better job offers, demanding perks and flexibilities like permanent remote work or expensive fertility benefits. But belt-tightening and market consolidation across health tech companies have tipped the scales back in favor of employers, who are continuing to hire — for a seemingly dwindling number of positions.

It might feel like a downturn, although it’s possible that the industry is simply easing back into its pre-pandemic normal, before the massive infusion of venture dollars and the hype surrounding virtual care, said Brookings Institution research fellow Niam Yaraghi, who studies health care employment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Obesity drugs seen as possible treatment for liver disease MASH

hotspot

WSS

CDC director unscathed in first congressional testimony

R1 RCM gets $5.8 billion buyout offer from private equity firm

The Harvard botanist who searched for psychedelics in the Amazon

Obesity drugs seen as possible treatment for liver disease MASH

Rep. Raul Ruiz on the physician shortage and more

New documents shed light on MD Anderson Cancer Institute feud

entertainment

hotspot

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

As biotech industry slumps, bioscience job market is upside down

Peter Hotez and the public health issue of online harassment

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

United colonoscopy coverage change 'may cost lives,' doctors say

Diagnostic tests are hitting their mathematical limits

After affirmative action ruling, medical educators look to 'holistic review'

A new nitrogen execution bill also undermines medical licensing

Hollywood unions extend contract negotiations for actors

The EPA's new lead rule: How one expert crunched the numbers

hotspot

CDC director unscathed in first congressional testimony

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Takeda, Janssen join wearable maker to measure scratching

He's a Nobel laureate. Critics say he was misleading on Covid

J&J to emphasize cancer drugs, stop much of its vaccine research

With clinical trial data readouts, here's how to spot spin

Wikipedia

leisure time

hotspot

focus